John A Baron

Author PubWeight™ 302.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005 15.46
2 Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010 10.85
3 Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007 7.93
4 A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003 6.99
5 Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 2009 5.05
6 Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 2004 4.42
7 Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am 2003 4.38
8 Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005 4.31
9 Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012 4.22
10 Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007 3.66
11 Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 2007 3.44
12 Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003 3.44
13 Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 2003 3.33
14 Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol 2013 3.31
15 Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 2009 3.15
16 Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 2007 3.14
17 Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2008 3.11
18 Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst 2013 3.06
19 Association of hospital and surgeon volume of total hip replacement with functional status and satisfaction three years following surgery. Arthritis Rheum 2003 2.98
20 Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012 2.77
21 Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003 2.72
22 One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med 2012 2.70
23 Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am 2005 2.67
24 Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009 2.64
25 Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 2012 2.57
26 Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 2009 2.56
27 A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2008 2.56
28 Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol 2010 2.50
29 Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut 2013 2.50
30 Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol 2013 2.46
31 Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007 2.39
32 Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet 2013 2.37
33 Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 2010 2.30
34 Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 2012 2.22
35 Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev 2013 2.14
36 Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 2008 2.12
37 Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008 2.11
38 Development of common data elements: the experience of and recommendations from the early detection research network. Int J Med Inform 2003 2.04
39 Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) 2011 2.03
40 Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res 2007 2.02
41 Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 2010 1.99
42 Survival after hip fracture. Osteoporos Int 2005 1.93
43 Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009 1.88
44 Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older. Arthritis Rheum 2007 1.78
45 Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 2008 1.73
46 Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 2007 1.73
47 Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev 2009 1.72
48 Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol 2013 1.71
49 Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011 1.70
50 Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 2004 1.67
51 Twelve-year risk of revision after primary total hip replacement in the U.S. Medicare population. J Bone Joint Surg Am 2012 1.67
52 Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry. Dis Colon Rectum 2013 1.65
53 Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) 2012 1.65
54 Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet 2012 1.64
55 Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010 1.64
56 Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst 2012 1.60
57 Survival following total hip replacement. J Bone Joint Surg Am 2005 1.57
58 Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002 1.56
59 Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013 1.55
60 Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ 2008 1.54
61 Fever of unknown origin and cancer: a population-based study. Lancet Oncol 2005 1.52
62 Early failures of total hip replacement: effect of surgeon volume. Arthritis Rheum 2004 1.50
63 Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study. Ann Intern Med 2015 1.50
64 BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Cancer Epidemiol Biomarkers Prev 2012 1.48
65 Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) 2008 1.47
66 Choice of hospital for revision total hip replacement. J Bone Joint Surg Am 2010 1.43
67 Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010 1.40
68 Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer Epidemiol Biomarkers Prev 2011 1.40
69 Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One 2010 1.36
70 The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 2009 1.35
71 Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res 2010 1.32
72 Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 2003 1.32
73 Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh. Am J Clin Nutr 2007 1.31
74 Risk factors for revision of primary total hip arthroplasty: a systematic review. BMC Musculoskelet Disord 2012 1.31
75 Departures from community equipoise may lead to incorrect inference in randomized trials. J Clin Epidemiol 2010 1.27
76 Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn 2011 1.27
77 Bilateral total knee replacement: staging and pulmonary embolism. J Bone Joint Surg Am 2006 1.25
78 Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev 2008 1.25
79 Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study. Hepatogastroenterology 2003 1.24
80 Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009 1.21
81 Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology 2006 1.21
82 Early life factors in relation to breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002 1.20
83 Contribution of hospital characteristics to the volume-outcome relationship: dislocation and infection following total hip replacement surgery. Arthritis Rheum 2002 1.17
84 TGFBR1*6A may contribute to hereditary colorectal cancer. J Clin Oncol 2005 1.16
85 Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 2004 1.15
86 Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila) 2010 1.15
87 Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007 1.13
88 Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr 2008 1.12
89 Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies. J Bone Miner Res 2011 1.11
90 Neighborhoods matter: use of hospitals with worse outcomes following total knee replacement by patients from vulnerable populations. Arch Intern Med 2007 1.11
91 Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst 2006 1.11
92 Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) 2008 1.11
93 Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer 2011 1.10
94 Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer 2011 1.09
95 Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010 1.07
96 Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev 2010 1.06
97 Positive predictive values of the International Classification of Disease, 10th edition diagnoses codes for diverticular disease in the Danish National Registry of Patients. Clin Exp Gastroenterol 2010 1.05
98 Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst 2009 1.05
99 Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev 2008 1.05
100 Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res 2010 1.05
101 The association of physical activity and body mass index with the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev 2005 1.04
102 Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 2006 1.03
103 Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev 2010 1.03
104 Quality of colonoscopy reporting: a process of care study. Am J Gastroenterol 2002 1.03
105 Accuracy of colorectal polyp self-reports: findings from the colon cancer family registry. Cancer Epidemiol Biomarkers Prev 2007 1.03
106 Mortality and pulmonary embolism after fracture in the elderly. Osteoporos Int 2003 1.02
107 Utilization of low-volume hospitals for total hip replacement. Arthritis Rheum 2004 1.02
108 Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 2002 1.01
109 A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2010 0.99
110 Gene-specific differential DNA methylation and chronic arsenic exposure in an epigenome-wide association study of adults in Bangladesh. Environ Health Perspect 2014 0.98
111 Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. Eur J Cancer 2011 0.97
112 A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev 2012 0.97
113 Predictive value of Medicare claims data for identifying revision of index hip replacement was modest. J Clin Epidemiol 2010 0.97
114 Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study. BMC Cancer 2008 0.97
115 Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2010 0.96
116 What now for aspirin and cancer prevention? J Natl Cancer Inst 2004 0.96
117 Curcumin chemoprevention: the long road to clinical translation. Cancer Prev Res (Phila) 2011 0.96
118 IκBKβ and NFκB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2012 0.95
119 Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol 2011 0.95
120 Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control 2006 0.95
121 Chemoprevention in gastrointestinal cancers: current status. Basic Clin Pharmacol Toxicol 2006 0.95
122 Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab 2014 0.95
123 Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer. Epigenetics 2013 0.94
124 Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev 2008 0.94
125 Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction. Int J Epidemiol 2013 0.93
126 Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 2014 0.93
127 Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux. Clin Gastroenterol Hepatol 2012 0.93
128 Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst 2009 0.92
129 Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2009 0.92
130 Early life risk factors in cancer: the relation of birth weight to adult obesity. Int J Cancer 2003 0.92
131 CT screening for lung cancer: spiraling into confusion? JAMA 2007 0.92
132 Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut 2013 0.92
133 Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer 2013 0.92
134 COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control 2013 0.92
135 Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control 2009 0.92
136 Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med 2009 0.92
137 Baseline comorbidities in a skin cancer prevention trial in Bangladesh. Eur J Clin Invest 2013 0.91
138 Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung 2010 0.91
139 Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds - gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. Drugs R D 2011 0.91
140 Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation 2011 0.89
141 Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study. Inflamm Bowel Dis 2013 0.89
142 Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry. Cancer Prev Res (Phila) 2011 0.88
143 Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol 2005 0.88
144 Neither long-term statin use nor atherosclerotic disease is associated with risk of colorectal cancer. Clin Gastroenterol Hepatol 2010 0.87
145 K-ras mutations in incident sporadic colorectal adenomas. Cancer 2006 0.87
146 Matching colonoscopy and pathology data in population-based registries: development of a novel algorithm and the initial experience of the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2011 0.87
147 Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control 2009 0.87
148 Aspirin and cancer: trials and observational studies. J Natl Cancer Inst 2012 0.87
149 Heritability and familial aggregation of diverticular disease: a population-based study of twins and siblings. Gastroenterology 2013 0.87
150 Arsenic and lung disease mortality in Bangladeshi adults. Epidemiology 2014 0.87
151 Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer 2010 0.86
152 Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis 2013 0.86
153 Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005 0.86
154 Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol 2008 0.85
155 Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study. Breast Cancer Res 2010 0.85
156 Development and validation of an index of musculoskeletal functional limitations. BMC Musculoskelet Disord 2009 0.84
157 Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013 0.84
158 Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry. Mod Pathol 2012 0.84
159 High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry. Fam Cancer 2014 0.83
160 Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005 0.83
161 Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events. Eur J Clin Invest 2011 0.83
162 Cancer and venous thromboembolism: a multidisciplinary approach. Clin Lab 2003 0.82
163 NO excess risk of breast cancer among female users of systemic glucocorticoids. Cancer Epidemiol Biomarkers Prev 2005 0.82
164 Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metabolism 2007 0.82
165 Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol 2007 0.82
166 Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation. Cancer Epidemiol Biomarkers Prev 2010 0.82
167 Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010 0.82
168 Development and validation of a registry-based definition of eosinophilic esophagitis in Denmark. World J Gastroenterol 2013 0.81
169 Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers. Metabolism 2004 0.81
170 Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. PLoS One 2013 0.81
171 Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2013 0.81
172 Dietary fiber and colorectal cancer: an ongoing saga. JAMA 2005 0.81
173 Folate and colo-rectal cancer risk. Br J Nutr 2007 0.81
174 Uracil misincorporation into DNA and folic acid supplementation. Am J Clin Nutr 2009 0.80
175 MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial. Cancer Epidemiol Biomarkers Prev 2008 0.80
176 Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol 2013 0.80
177 Risk of colorectal cancer in patients with acute myocardial infarction and stroke: a nationwide cohort study. Cancer Epidemiol Biomarkers Prev 2013 0.80
178 Risk factors for revision of primary total hip replacement: results from a national case-control study. Arthritis Care Res (Hoboken) 2012 0.79
179 Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention. Cancer Prev Res (Phila) 2011 0.79
180 Cholecystectomy and the risk of recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2007 0.79
181 Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2003 0.78
182 Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation. Br J Clin Pharmacol 2012 0.78
183 Hypercoagulability preceding cancer. Venous thromboembolism and subsequent cancer risk. J Thromb Haemost 2005 0.77
184 CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control 2012 0.77
185 Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2003 0.77
186 Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry. Genes Chromosomes Cancer 2014 0.76
187 (Nutritional) chemoprevention of cancer: what's up? J Natl Cancer Inst 2006 0.75
188 Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med 2016 0.75
189 Serum salicylate levels and risk of recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2011 0.75
190 Can aspirin keep mortality at bay? Arch Intern Med 2007 0.75
191 The age-at-diagnosis fallacy. Arch Intern Med 2006 0.75
192 Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark 2011 0.75
193 Effects of folic acid plus vitamin B12 vs placebo in myocardial infarction survivors. JAMA 2010 0.75
194 Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia? J Clin Gastroenterol 2017 0.75